Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly
β Scribed by Cesare Gridelli; Erminia Massarelli; Paolo Maione; Antonio Rossi; Roy S. Herbst; Amir Onn; Fortunato Ciardiello
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 151 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. The objective of this study was to assess the value of combinedβmodality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l
## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twiceβdaily radiotherapy (BIDRT) or onceβdaily radiotherapy (QDRT) resulted in a better outcome for patients with limitedβst
## Abstract ## BACKGROUND DNA damage sensor proteins have received much attention as upstream components of the DNA damage checkpoint signaling pathway that are required for cell cycle control and the induction of apoptosis. Deficiencies in these proteins are directly linked to the accumulation of
The current treatment paradigm for patients with advanced laryngeal squamous cell carcinoma continues to evolve. The authors assembled a panel of experts from the fields of medical oncology, radiation oncology, and surgery to discuss treatment options and to defend their positions.